Who owns BioCryst Pharmaceuticals?

Key details on BioCryst Pharmaceuticals (Ticker: BCRX)

Who owns BioCryst Pharmaceuticals?

Is BCRX a good stock to own? Find out who bought BioCryst Pharmaceuticals, who sold BioCryst Pharmaceuticals (BCRX) stock, and who holds a large position in BioCryst Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Baker Bros. Advisors 14.22M $146.73M Dec. 31, 2015
FMR 7.49M $77.28M Dec. 31, 2015
Wellington Management Company 7.47M $77.09M Dec. 31, 2015
RA Capital Management 3.09M $31.93M Dec. 31, 2015
Vanguard 2.81M $28.99M Dec. 31, 2015
BlackRock Fund Advisors 2.79M $28.79M Dec. 31, 2015
D. E. Shaw & Co 2.57M $26.49M Dec. 31, 2015
Millennium Management 2.43M $21.95M March 31, 2015
STATE STREET CORPORATION 2.11M $21.82M Dec. 31, 2015
RTW INVESTMENTS 1.97M $20.36M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 1.81M $18.63M Dec. 31, 2015
SUSQUEHANNA INTERNATIONAL 1.74M $18.46M March 31, 2014
VHCP Management 1.74M $15.75M March 31, 2015
Franklin Resources 1.66M $17.11M Dec. 31, 2015
Deerfield Management Company 1.63M $11.88M Sept. 30, 2013
QVT Financial 1.36M $14.02M Dec. 31, 2015
Jennison Associates 1.35M $13.92M Dec. 31, 2015
Technical Financial Services 1.21M $8.84M Sept. 30, 2013
TPG Group Holdings 1.16M $12.30M March 31, 2014
TPG Capital 1.16M $3.21M Sept. 30, 2011
GOLDMAN SACHS 1.11M $11.43M Dec. 31, 2015
T. Rowe Price Associates 1.11M $12.62M Sept. 30, 2015
Inves 1.11M $11.42M Dec. 31, 2015
Cormorant Asset Management 1.08M $11.15M Dec. 31, 2015